KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Supernus Pharmaceuticals (SUPN) Times Interest Earned: 2011-2023

Historic Times Interest Earned for Supernus Pharmaceuticals (SUPN) over the last 13 years, with Dec 2023 value amounting to -$2.18.

  • Supernus Pharmaceuticals' Times Interest Earned fell 408.31% to -$19.33 in Q2 2023 from the same period last year, while for Jun 2023 it was $3.56, marking a year-over-year increase of 6.79%. This contributed to the annual value of -$2.18 for FY2023, which is 133.44% down from last year.
  • As of FY2023, Supernus Pharmaceuticals' Times Interest Earned stood at -$2.18, which was down 133.44% from $6.52 recorded in FY2022.
  • Over the past 5 years, Supernus Pharmaceuticals' Times Interest Earned peaked at $7.31 during FY2020, and registered a low of -$2.18 during FY2023.
  • Moreover, its 3-year median value for Times Interest Earned was $3.67 (2021), whereas its average is $2.67.
  • As far as peak fluctuations go, Supernus Pharmaceuticals' Times Interest Earned soared by 77.63% in 2022, and later plummeted by 133.44% in 2023.
  • Over the past 5 years, Supernus Pharmaceuticals' Times Interest Earned (Yearly) stood at $6.54 in 2019, then grew by 11.76% to $7.31 in 2020, then slumped by 49.77% to $3.67 in 2021, then surged by 77.63% to $6.52 in 2022, then crashed by 133.44% to -$2.18 in 2023.